Physician profile
Paul T Hoff
NPI 1649301227
$43,954.24
in general payments reported to CMS, 2019-2025
12 companies · $29K in 2025
The $29K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,162 · 2020: $246 · 2021: $620 · 2022: $2,582 · 2023: $8,324 · 2024: $1,532 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Consulting Fee: $16K · Honoraria: $6,000 · Food and Beverage: $1,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,875.06 |
| Consulting Fee | $15,675.00 |
| Honoraria | $6,000.00 |
| Food and Beverage | $1,793.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $42,361.80 | 2019-2025 | Inspire |
| Ethicon INC. | $540.00 | 2022 | |
| Acclarent, INC | $275.74 | 2019-2023 | Acclarent Aera |
| Optinose US, INC. | $210.85 | 2019-2024 | |
| Hologic Sales and Service, LLC | $141.54 | 2025 | Coolseal Generator |
| Medtronic, INC. | $111.34 | 2025 | Pteye Parathyroid Detection System |
| Intuitive Surgical, INC. | $90.00 | 2021 | |
| Aerin Medical INC. | $59.97 | 2020-2024 | |
| Spirair, INC. | $59.21 | 2025 | |
| Intersect Ent, INC. | $55.11 | 2019-2020 | |
| Integra Lifesciences Corporation | $29.65 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Ars Pharmaceuticals Operations, INC. | $19.03 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Hoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.